![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 26, 2014 3:17:54 PM
Having finished a conversation with a very experienced trader I have hunch of what has happened and going to occur.
The lead investor is Dicilyon Consulting and Investment Ltd., an affiliate of Israeli investor David Edery. This investment firm is known for there due dilgence.
The rumor of that DRIO exes met with the FDA last weekend was a possible due diligence process of Dicilyon. Now no one knows when the approval will come through and they are saying spring 2015, but it is possible to ask for a review of submitted documents and to inquire if the FDA will ask to submit additional materials. Most circumstances the FDA will not give any sort of indication either way. However it was postive enough for Mr. Edery to say yes to the investment to move forward.
Also the two week time frame for the R/S also aligns with rumored next batch of FDA approvals on October 5th.
Another glucose meter not one that works with a smart phone was approved recently, they had submitted there paperwork only shortly earlier then DRIO did, and is in line with the FDA 9 month turn around.
I feel that longs will be very happy before the R/S and into the future. Good luck to all.
Recent DRIO News
- Dario Demonstrates 12 Months of Sustained Healthy Behavior Change for Members Taking a GLP-1 • PR Newswire (US) • 06/25/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:02:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:01:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 12:30:15 PM
- Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer • PR Newswire (US) • 06/05/2024 12:30:00 PM
- DarioHealth Reports First Quarter 2024 Financial and Operating Results • PR Newswire (US) • 05/15/2024 10:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 10:06:09 AM
- DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th • PR Newswire (US) • 05/07/2024 12:30:00 PM
- Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes • PR Newswire (US) • 04/25/2024 12:30:00 PM
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution • PR Newswire (US) • 04/18/2024 12:30:00 PM
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health • PR Newswire (US) • 04/10/2024 12:30:00 PM
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health • PR Newswire (US) • 04/02/2024 12:30:00 PM
- DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results • PR Newswire (US) • 03/28/2024 10:30:00 AM
- DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH • PR Newswire (US) • 03/21/2024 12:30:00 PM
- New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications • PR Newswire (US) • 03/12/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:21:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:20:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:19:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:16:57 PM
- DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE • PR Newswire (US) • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:05:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM